A New Dawn: Canadian Exodus & Alternative Capital
|Zach Haigney||Sep 28|
With COMPASS Pathways' listing and early success on NASDAQ, a clear precedent is set. The premise of psychedelic medicine has been accepted by more extensive and more scrupulous investors and institutions.
The Canadian Exodus
Last Monday, three days after COMPASS’s IPO, MindMed promptly announced plans to up-list to the NASDAQ.
"Mind Medicine... is evaluat…